Literature DB >> 570850

Critical micelle concentrations of gangliosides.

S Formisano, M L Johnson, G Lee, S M Aloj, H Edelhoch.   

Abstract

The micellar properties of mixed, bovine gangliosides and purified galactosyl-N-acetylacetylgalactosaminyl (N-acetylneuraminyl) galactosylglucosylceramide were studied by gel filtration, equilibrium dialysis, and band and boundary centrifugation in sucrose gradients. The dissociation of micelles is very slow (days) in water and required us to approach equilibrium by association of monomers rather than by the dissociation of micelles. The gangliosides were therefore first converted into very low molecular weight aggregates (1-3 molecules) by dissolving them in Me2SO. Galactosyl-N-acetylgalactosaminyl(N-acetylneuraminyl)galactosylglucosylceramide was then diluted into aqueous sucrose gradients and sedimented by the boundary centrifugation technique. This gave a sedimenting micelle and a nonsedimenting monomer concentration of (1-2) x 10-10 M (or less) which corresponds to the critical micelle concentration value. The mixed gangliosides revealed two micellar sizes (i.e., 10 and 4.5 S), the slower sedimenting species being formed from the larger one with time (days). The critical micelle concentration of the mixed gangliosides was found to be approximately 10-8 M by a gel filtration, equilibrium dialysis, and band centrifugation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 570850     DOI: 10.1021/bi00573a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Purification of non-infectious ganglioside preparations from scrapie-infected brain tissue.

Authors:  A Di Martino; J Safar; M Ceroni; C J Gibbs
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Thermotropic phase behavior and stability of monosialoganglioside micelles in aqueous solution.

Authors:  M Hirai; T Takizawa; S Yabuki; Y Nakata; K Hayashi
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

3.  Quantitative description of the binding of GM1 oligosaccharide by cholera enterotoxin.

Authors:  D E Schafer; A K Thakur
Journal:  Cell Biophys       Date:  1982-03

4.  Purification and characterization of Clostridium perfringens delta-toxin.

Authors:  J E Alouf; C Jolivet-Reynaud
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

5.  Kinetics of Vibrio cholerae sialidase action on gangliosidic substrates at different supramolecular-organizational levels.

Authors:  B Venerando; B Cestaro; A Fiorilli; R Ghidoni; A Preti; G Tettamanti
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

6.  Point mutational analysis of the liganding site in human glycolipid transfer protein. Functionality of the complex.

Authors:  Margarita L Malakhova; Lucy Malinina; Helen M Pike; Alexander T Kanack; Dinshaw J Patel; Rhoderick E Brown
Journal:  J Biol Chem       Date:  2005-05-18       Impact factor: 5.157

7.  Alpha-fucosidase-ganglioside interactions. Action of alpha-L-fucosidase from the hepatopancreas of Octopus vulgaris on a fucose-containing ganglioside (Fuc-GM1).

Authors:  M Masserini; A Giuliani; B Venerando; A Fiorilli; A D'Aniello; G Tettamanti
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

8.  Endocytosis of exogenous GM1 ganglioside and cholera toxin by neuroblastoma cells.

Authors:  N K Gonatas; A Stieber; J Gonatas; T Mommoi; P H Fishman
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

9.  Cryoprecipitation of an anti-Pr2 monoclonal IgM cold agglutinin in the presence of GM3 ganglioside.

Authors:  P Yeni; M L Harpin; B Habibi; A Billecocq; M J Morelec; J P Clauvel; F Danon; N Baumann; J C Brouet
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.

Authors:  M Rusnati; E Tanghetti; C Urbinati; G Tulipano; S Marchesini; M Ziche; M Presta
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.